Hackensack, New Jersey (June 11, 2012) – The Lymphoma Research Foundation (LRF), the nation's largest nonprofit organization devoted exclusively to lymphoma, in collaboration with John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, will bring together top lymphoma experts to discuss the latest practices in the diagnosis and management of lymphoma on Wednesday, June 20 from 6:00 pm – 8:30 pm at the Philadelphia Westin Hotel. This seminar is the final installation of LRF's 2011-2012 Philadelphia Lymphoma Rounds program, a continuing medical education (CME) series focused on the diagnosis and treatment of lymphoma patients.
"Lymphoma Rounds are an integral part of the Lymphoma Research Foundation's professional education services," said Brian Tomlinson, LRF's Chief Program Officer. "This is a great opportunity for physicians and healthcare professionals to review case studies and have specific questions answered from our expert speaking faculty comprised of lymphoma specialists."
The Lymphoma Philadelphia Rounds CME program provides a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts. This seminar's experts will discuss Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma. How we diagnose and treat lymphoma is constantly evolving," said Anthony Mato, M.D., M.S., Program Chair and Lymphoma Oncologist at John Theurer Cancer Center. " The Philadelphia Rounds Program is an excellent forum for physicians in lymphoma oncology to learn best practices to treat complicated cases and remain on the cutting-edge of research in their field."
The Philadelphia Lymphoma Rounds program is free for healthcare professionals, however, pre-registration is required. Food and refreshments will be provided for registered participants. The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1.5 AMA PRA Category I Credit. Parking vouchers will be provided at the registration table for those parked in the Liberty Place Parking Garage, below the Westin. For additional information please contact Maxwell Mulcahy at the Lymphoma Research Foundation at firstname.lastname@example.org.
The Lymphoma Research Foundation is presenting this meeting in collaboration with the John Theurer Cancer Center, Cooper University Hospital, Fox Chase Cancer Center, Helen F. Graham Cancer Center, Thomas Jefferson University, University of Pennsylvania, and Vita Medical Associates.
About the John Theurer Cancer Center at Hackensack University Medical Center
John Theurer Cancer Center at Hackensack University Medical Center is among the nation's top 50 U.S. News and World Report Best Hospitals for cancer – the only cancer center in New Jersey with this designation. It is New Jersey's largest and most comprehensive cancer center dedicated to the diagnosis, treatment, management, research, screenings, preventive care, as well as survivorship of patients with all types of cancer.
Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. The 14 specialized divisions feature a team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. The John Theurer Cancer Center provides comprehensive multidisciplinary care, state of the art technology, access to clinical trials, compassionate care and medical expertise—all under one roof. For more information please visit jtcancercenter.org.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted exclusively to funding innovative research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. LRF's mission is to eradicate lymphoma and serve those touched by this disease.
LRF remains dedicated to finding a cure for lymphoma through an aggressively-funded research program, and by supporting the development of improved therapies for people living with lymphoma. To date, the Foundation has awarded more than $50 million in lymphoma-specific research. The Foundation also provides a comprehensive series of programs and services for people with lymphoma, their loved ones and caregivers. For additional information on LRF's programs and services, visit lymphoma.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.